Shenghe Bioscience - B (02898.HK) announced its interim performance for the six months ending in June. Other income recorded RMB 1.78 million (same below), a 70.4% decrease from the previous year. The loss attributable to owners narrowed from RMB 61.49 million in the same period last year to RMB 36.08 million, with a loss per share of 34 cents. No interim dividend will be distributed.
《業績》盛禾生物(02898.HK)中期虧損收窄至3,608萬人民幣
The interim loss of Shenghe Bio (02898.HK) narrowed to 36.08 million RMB.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.